ACAD logo

ACADIA Pharmaceuticals (ACAD) Revenue

Annual Revenue

$957.80 M
+$231.36 M+31.85%

December 31, 2024

Summary

Performance

1-Year Change

+31.85%

3-Year Change

+97.83%

5-Year Change

+182.47%

15-Year Change

+666.84%

ACAD Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

79.84%
ACAD annual revenue is higher than 79.84% of companies in Healthcare sector

Analysts Estimate

$1.06 B
ACAD annual revenue is currently -9.81% lower than the consensus analysts' forecast

High & Low

All-time High

$957.80 M
ACAD annual revenue is currently at an all-time high

3-Year Low

$484.14 M
ACAD annual revenue is currently +97.83% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
ACAD previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
ACAD next annual earnings announcement has not yet been scheduled

OtherACADprofitabilitymetrics:

Annual EPS

$1.36
ACAD annual earnings per share is $1.36

Annual Net Income

$226.45 M
ACAD annual net profit is $226.45 million

Annual Operating Profit

$84.28 M
ACAD annual operating income is $84.28 million

Annual Gross Profit

$875.96 M
ACAD annual gross profit is $875.96 million

Quarterly Revenue

$259.60 M
+$9.20 M+3.67%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+98.54%

5-Year Change

+164.02%

ACAD Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

78.37%
ACAD quarterly revenue is higher than 78.37% of companies in Healthcare sector

Analysts Estimate

$239.34 M
ACAD quarterly revenue is currently +8.47% higher than the consensus analysts' forecast

High & Low

All-time High

$259.60 M
ACAD quarterly revenue is currently at an all-time high

3-Year Low

$115.47 M
ACAD quarterly revenue is currently +124.83% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
ACAD previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 8, 2025
ACAD next earnings announcement is scheduled for May 8, 2025

Related metrics

Quarterly Gross Profit

$237.80 M
ACAD quarterly gross profit is $237.80 million

Quarterly Operating Profit

$6.99 M
ACAD quarterly operating income is $6.99 million

Quarterly Net Income

$143.74 M
ACAD quarterly net profit is $143.74 million

Quarterly EPS

$0.86
ACAD quarterly earnings per share is $0.86

TTM Revenue

$957.80 M
+$28.56 M+3.07%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+97.83%

5-Year Change

+182.47%

ACAD TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

78%
ACAD TTM revenue is higher than 78% of companies in Healthcare sector

Analysts Estimate

$991.30 M
ACAD TTM revenue is currently -3.38% lower than the consensus analysts' forecast

High & Low

All-time High

$957.80 M
ACAD TTM revenue is currently at an all-time high

3-Year Low

$484.14 M
ACAD TTM revenue is currently +97.83% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
ACAD previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 8, 2025
ACAD next earnings announcement is scheduled for May 8, 2025

OtherACADprofitabilitymetrics:

TTM Gross Profit

$875.96 M
ACAD TTM gross profit is $875.96 million

TTM Operating Profit

$84.28 M
ACAD TTM operating income is $84.28 million

TTM Net Income

$226.45 M
ACAD TTM net profit is $226.45 million

TTM EPS

$1.36
ACAD TTM earnings per share is $1.36

ACAD Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+31.9%0.0%0.0%
3 y3 years+97.8%+98.5%+97.8%
5 y5 years+182.5%+164.0%+182.5%

ACAD Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+97.8%at high+124.8%at high+97.8%
5 y5-yearat high+182.5%at high+188.2%at high+182.5%
alltimeall timeat high>+9999.0%at high>+9999.0%at high>+9999.0%

ACADIA Pharmaceuticals Revenue History

DateAnnualQuarterlyTTM
Dec 2024
$957.80 M(+31.8%)
$259.60 M(+3.7%)
$957.80 M(+3.1%)
Sep 2024
-
$250.40 M(+3.5%)
$929.24 M(+4.3%)
Jun 2024
-
$241.96 M(+17.6%)
$890.53 M(+9.4%)
Mar 2024
-
$205.83 M(-10.9%)
$813.81 M(+12.0%)
Dec 2023
$726.44 M(+40.4%)
$231.04 M(+9.1%)
$726.44 M(+15.0%)
Sep 2023
-
$211.70 M(+28.1%)
$631.89 M(+14.7%)
Jun 2023
-
$165.24 M(+39.5%)
$550.90 M(+5.9%)
Mar 2023
-
$118.46 M(-13.2%)
$520.23 M(+0.6%)
Dec 2022
$517.24 M(+6.8%)
$136.49 M(+4.4%)
$517.24 M(+1.1%)
Sep 2022
-
$130.71 M(-2.9%)
$511.50 M(-0.2%)
Jun 2022
-
$134.56 M(+16.5%)
$512.40 M(+3.9%)
Mar 2022
-
$115.47 M(-11.7%)
$493.06 M(+1.8%)
Dec 2021
$484.14 M(+9.6%)
$130.76 M(-0.6%)
$484.14 M(+2.1%)
Sep 2021
-
$131.61 M(+14.2%)
$474.39 M(+2.4%)
Jun 2021
-
$115.22 M(+8.1%)
$463.36 M(+1.1%)
Mar 2021
-
$106.55 M(-11.9%)
$458.24 M(+3.7%)
Dec 2020
$441.75 M(+30.3%)
$121.01 M(+0.4%)
$441.75 M(+5.4%)
Sep 2020
-
$120.58 M(+9.5%)
$419.07 M(+6.6%)
Jun 2020
-
$110.10 M(+22.2%)
$393.08 M(+7.3%)
Mar 2020
-
$90.07 M(-8.4%)
$366.19 M(+8.0%)
Dec 2019
$339.08 M(+51.5%)
$98.33 M(+4.0%)
$339.08 M(+12.9%)
Sep 2019
-
$94.59 M(+13.7%)
$300.32 M(+13.7%)
Jun 2019
-
$83.20 M(+32.2%)
$264.04 M(+11.0%)
Mar 2019
-
$62.96 M(+5.7%)
$237.90 M(+6.3%)
Dec 2018
$223.81 M(+79.2%)
$59.57 M(+2.2%)
$223.81 M(+7.7%)
Sep 2018
-
$58.30 M(+2.2%)
$207.80 M(+12.3%)
Jun 2018
-
$57.06 M(+16.8%)
$185.07 M(+16.8%)
Mar 2018
-
$48.87 M(+12.2%)
$158.48 M(+26.9%)
Dec 2017
$124.90 M(+620.7%)
$43.56 M(+22.4%)
$124.90 M(+33.9%)
Sep 2017
-
$35.58 M(+16.7%)
$93.30 M(+48.1%)
Jun 2017
-
$30.48 M(+99.4%)
$62.99 M(+93.1%)
Mar 2017
-
$15.29 M(+27.8%)
$32.61 M(+88.2%)
Dec 2016
$17.33 M(>+9900.0%)
$11.96 M(+127.1%)
$17.33 M(+221.8%)
Sep 2016
-
$5.27 M(+5330.9%)
$5.39 M(+3330.6%)
Jun 2016
-
$97.00 K(+2325.0%)
$157.00 K(+157.4%)
Mar 2016
-
$4000.00(-76.5%)
$61.00 K(0.0%)
Dec 2015
$61.00 K(-49.2%)
$17.00 K(-56.4%)
$61.00 K(-33.7%)
Sep 2015
-
$39.00 K(+3800.0%)
$92.00 K(+35.3%)
Jun 2015
-
$1000.00(-75.0%)
$68.00 K(-28.4%)
Mar 2015
-
$4000.00(-91.7%)
$95.00 K(-21.5%)
Dec 2014
$120.00 K(-89.5%)
$48.00 K(+220.0%)
$121.00 K(+10.0%)
Sep 2014
-
$15.00 K(-46.4%)
$110.00 K(-67.2%)
Jun 2014
-
$28.00 K(-6.7%)
$335.00 K(-55.8%)
Mar 2014
-
$30.00 K(-18.9%)
$758.00 K(-33.8%)
Dec 2013
$1.15 M
$37.00 K(-84.6%)
$1.15 M(-23.1%)
DateAnnualQuarterlyTTM
Sep 2013
-
$240.00 K(-46.8%)
$1.49 M(-68.5%)
Jun 2013
-
$451.00 K(+8.2%)
$4.73 M(-3.0%)
Mar 2013
-
$417.00 K(+9.7%)
$4.87 M(-0.7%)
Dec 2012
$4.91 M(+137.4%)
$380.00 K(-89.1%)
$4.91 M(-4.1%)
Sep 2012
-
$3.48 M(+480.6%)
$5.12 M(+130.3%)
Jun 2012
-
$599.00 K(+33.1%)
$2.22 M(+6.7%)
Mar 2012
-
$450.00 K(-23.5%)
$2.08 M(+0.7%)
Dec 2011
$2.07 M(-95.1%)
$588.00 K(+0.7%)
$2.07 M(-94.4%)
Sep 2011
-
$584.00 K(+27.0%)
$36.88 M(-4.4%)
Jun 2011
-
$460.00 K(+5.7%)
$38.60 M(-4.5%)
Mar 2011
-
$435.00 K(-98.8%)
$40.44 M(-4.0%)
Dec 2010
$42.13 M(+558.5%)
$35.40 M(+1438.6%)
$42.13 M(+395.7%)
Sep 2010
-
$2.30 M(+0.2%)
$8.50 M(-1.6%)
Jun 2010
-
$2.30 M(+7.7%)
$8.63 M(+5.8%)
Mar 2010
-
$2.13 M(+20.6%)
$8.16 M(+27.5%)
Dec 2009
$6.40 M(+302.5%)
$1.77 M(-27.4%)
$6.40 M(+29.1%)
Sep 2009
-
$2.44 M(+33.8%)
$4.95 M(+76.9%)
Jun 2009
-
$1.82 M(+386.6%)
$2.80 M(+141.9%)
Mar 2009
-
$374.00 K(+15.1%)
$1.16 M(-27.2%)
Dec 2008
$1.59 M(-79.0%)
$325.00 K(+15.2%)
$1.59 M(-44.2%)
Sep 2008
-
$282.00 K(+59.3%)
$2.85 M(-37.0%)
Jun 2008
-
$177.00 K(-78.0%)
$4.52 M(-29.3%)
Mar 2008
-
$806.00 K(-49.1%)
$6.40 M(-15.3%)
Dec 2007
$7.55 M(-7.1%)
$1.58 M(-19.1%)
$7.55 M(-2.5%)
Sep 2007
-
$1.96 M(-4.8%)
$7.75 M(+0.2%)
Jun 2007
-
$2.06 M(+4.8%)
$7.73 M(+2.3%)
Mar 2007
-
$1.96 M(+10.5%)
$7.56 M(-7.1%)
Dec 2006
$8.13 M(-25.8%)
$1.77 M(-8.7%)
$8.13 M(-7.6%)
Sep 2006
-
$1.94 M(+3.3%)
$8.80 M(-16.4%)
Jun 2006
-
$1.88 M(-25.9%)
$10.53 M(-5.7%)
Mar 2006
-
$2.54 M(+3.8%)
$11.17 M(+1.9%)
Dec 2005
$10.96 M(+138.0%)
$2.44 M(-33.5%)
$10.96 M(+14.2%)
Sep 2005
-
$3.67 M(+46.0%)
$9.60 M(+27.9%)
Jun 2005
-
$2.52 M(+8.2%)
$7.50 M(+25.0%)
Mar 2005
-
$2.33 M(+114.7%)
$6.01 M(+30.4%)
Dec 2004
$4.60 M(-37.6%)
$1.08 M(-31.5%)
$4.60 M(-14.2%)
Sep 2004
-
$1.58 M(+55.7%)
$5.37 M(-4.7%)
Jun 2004
-
$1.02 M(+9.9%)
$5.63 M(-18.4%)
Mar 2004
-
$923.90 K(-49.9%)
$6.89 M(-11.8%)
Dec 2003
$7.38 M(+17.6%)
$1.84 M(0.0%)
$7.82 M(+30.9%)
Sep 2003
-
$1.84 M(-19.1%)
$5.98 M(+44.7%)
Jun 2003
-
$2.28 M(+23.3%)
$4.13 M(+123.3%)
Mar 2003
-
$1.85 M
$1.85 M
Dec 2002
$6.28 M(+69.0%)
-
-
Dec 2001
$3.71 M(-13.9%)
-
-
Dec 2000
$4.31 M
-
-

FAQ

  • What is ACADIA Pharmaceuticals annual revenue?
  • What is the all time high annual revenue for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals annual revenue year-on-year change?
  • What is ACADIA Pharmaceuticals quarterly revenue?
  • What is the all time high quarterly revenue for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals quarterly revenue year-on-year change?
  • What is ACADIA Pharmaceuticals TTM revenue?
  • What is the all time high TTM revenue for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals TTM revenue year-on-year change?

What is ACADIA Pharmaceuticals annual revenue?

The current annual revenue of ACAD is $957.80 M

What is the all time high annual revenue for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high annual revenue is $957.80 M

What is ACADIA Pharmaceuticals annual revenue year-on-year change?

Over the past year, ACAD annual revenue has changed by +$231.36 M (+31.85%)

What is ACADIA Pharmaceuticals quarterly revenue?

The current quarterly revenue of ACAD is $259.60 M

What is the all time high quarterly revenue for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high quarterly revenue is $259.60 M

What is ACADIA Pharmaceuticals quarterly revenue year-on-year change?

Over the past year, ACAD quarterly revenue has changed by $0.00 (0.00%)

What is ACADIA Pharmaceuticals TTM revenue?

The current TTM revenue of ACAD is $957.80 M

What is the all time high TTM revenue for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high TTM revenue is $957.80 M

What is ACADIA Pharmaceuticals TTM revenue year-on-year change?

Over the past year, ACAD TTM revenue has changed by $0.00 (0.00%)